Lack of Circadian Variation of Pulse Wave Velocity Measurements in Healthy Volunteers

Carregando...
Imagem de Miniatura
Citações na Scopus
14
Tipo de produção
article
Data de publicação
2011
Editora
WILEY-BLACKWELL
Indexadores
Título da Revista
ISSN da Revista
Título do Volume
Autor de Grupo de pesquisa
Editores
Coordenadores
Organizadores
Citação
JOURNAL OF CLINICAL HYPERTENSION, v.13, n.1, p.19-22, 2011
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Arterial stiffness is an independent marker of cardiovascular events. Pulse wave velocity (PWV) is a validated method to detect arterial stiffness that can be influenced by several factors including age and blood pressure. However, it is not clear whether PWV could be influenced by circadian variations. In the present study, the authors measured blood pressure and carotid-femoral PWV measurements in 15 young healthy volunteers in 4 distinct periods: 8 am, noon, 4 pm, and 8 pm. No significant variations of systolic (P=.92), mean (P=.77), and diastolic (P=.66) blood pressure among 8 am (113 +/- 15, 84 +/- 8, 69 +/- 6 mm Hg), noon (114 +/- 13, 83 +/- 8, 68 +/- 6 mm Hg), 4 pm (114 +/- 13, 85 +/- 8, 70 +/- 7 mm Hg), and 8 pm (113 +/- 7, 83 +/- 10, 68 +/- 7 mm Hg), respectively, were observed. Similarly, carotid-femoral PWV did not change among the periods (8 am: 7.6 +/- 1.4 m/s, noon: 7.4 +/- 1.1 m/s, 4 pm: 7.6 +/- 1.0 m/s, 8 pm, 7.6 +/- 1.3 m/s; P=.85). Considering all measurements, mean blood pressure significantly correlated with PWV (r=.31; P=.016). In young healthy volunteers, there is no significant circadian variation of carotid-femoral PWV. These findings support the concept that it does not appear mandatory to perform PWV measurements at exactly the same period of the day. J Clin Hypertens (Greenwich). 2011;13:19-22. (c) 2010 Wiley Periodicals, Inc.
Palavras-chave
Referências
  1. Wang XK, 2008, CARDIOVASC THER, V26, P214, DOI 10.1111/j.1755-5922.2008.00051.x
  2. Laurent S, 2006, EUR HEART J, V27, P2588, DOI 10.1093/eurheartj/ehl254
  3. Netzer NC, 1999, ANN INTERN MED, V131, P485
  4. Drager LF, 2005, AM J RESP CRIT CARE, V172, P613, DOI 10.1164/rccm.200503-340OC
  5. ASMAR R, 1995, HYPERTENSION, V26, P485
  6. Kollias GE, 2009, J HUM HYPERTENS, V23, P597, DOI 10.1038/jhh.2009.2
  7. Cohen MC, 1997, AM J CARDIOL, V79, P1512
  8. Satoh H, 2009, HYPERTENS RES, V32, P1067, DOI 10.1038/hr.2009.158
  9. Mancia G, 2007, EUR HEART J, V28, P1462, DOI 10.1093/eurheartj/ehm236
  10. Drager LF, 2009, J HYPERTENS, V27, P1655, DOI 10.1097/HJH.0b013e32832c6982
  11. Otto ME, 2004, CIRCULATION, V109, P2507, DOI 10.1161/01.CIR.0000128207.26863.C4
  12. Drager LF, 2010, AM J HYPERTENS, V23, P249, DOI 10.1038/ajh.2009.246
  13. Cohen M.C., 1998, AM J CARDIOL, V79, p[1512, 260]
  14. JOHNS MW, 1991, SLEEP, V14, P540
  15. Ter Avest E, 2005, CLIN SCI, V108, P425
  16. Willum-Hansen Tine, 2006, Circulation, V113, P664, DOI 10.1161/CIRCULATIONAHA.105.579342